title: Adenovirus-mediated small hairpin RNA targeting Bcl-XL as therapy for colon cancer.
abstract: Bcl-XL, an anti-apoptotic protein of Bcl-2 family, is overexpressed in colon cancers. To determine Bcl-XL's potential feasibility as a therapeutic target, we constructed a recombinant adenovirus that expressed a U6 promoter-driven small hairpin RNA (shRNA) targeting Bcl-XL (Ad/Bcl-XL shRNA) and evaluated the vector's ability to induce RNA interference in vivo and alter apoptosis induction in colon cancer cells and tumours. Ad/Bcl-XL shRNA effectively knocked down Bcl-XL expression in colon cancer cells and decreased their viability. Treatment with Ad/Bcl-XL shRNA but not control vectors led to dramatically increased cleavage of cellular apoptosis-related enzymes caspase-9, caspase-3 and poly(ADP-ribose) polymerase. Ad/Bcl-XL shRNA also significantly suppressed the growth of subcutaneous tumours derived from DLD1 cells in a nude mouse model and did so without causing any obvious damage to normal tissues or normal human fibroblasts. Together, our results support the feasibility of using adenovirus-mediated RNA interference therapy targeting Bcl-XL against colon cancers and warrant further studies of its safety and efficacy.
authors.affiliation: Department of Colorectal Surgery, Sir Run Run Shaw Hospital, Zhejiang University, Zhejiang, China.
authors.forename: Hongbo
authors.initials: H
authors.lastname: Zhu
authors.forename: Yuping
authors.initials: Y
authors.lastname: Zhu
authors.forename: Jingzi
authors.initials: J
authors.lastname: Hu
authors.forename: Wenxian
authors.initials: W
authors.lastname: Hu
authors.forename: Yongqiang
authors.initials: Y
authors.lastname: Liao
authors.forename: Jun
authors.initials: J
authors.lastname: Zhang
authors.forename: Da
authors.initials: D
authors.lastname: Wang
authors.forename: Xuefeng
authors.initials: X
authors.lastname: Huang
authors.forename: Bingliang
authors.initials: B
authors.lastname: Fang
authors.forename: Chao
authors.initials: C
authors.lastname: He
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics / Q000628:therapy*; D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D017209:Apoptosis; D001483:Base Sequence; D015153:Blotting, Western; D003110:Colonic Neoplasms / Q000235:genetics / Q000628:therapy*; D015870:Gene Expression; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D007150:Immunohistochemistry; D051379:Mice; D008819:Mice, Nude; D008969:Molecular Sequence Data; D011401:Promoter Regions, Genetic; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis; D034622:RNA Interference; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D051028:bcl-2-Associated X Protein / Q000096:biosynthesis; D051020:bcl-X Protein / Q000235:genetics*
chemical_list: C494811:BCL2L1 protein, human; D019253:Proto-Oncogene Proteins c-bcl-2; D012333:RNA, Messenger; D051028:bcl-2-Associated X Protein; D051020:bcl-X Protein